Cite
HARVARD Citation
Ichimura, K. et al. (n.d.). ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS. Neuro-oncology. pp. vi12-vi13. [Online].